1. Home
  2. GBIO vs WIMI Comparison

GBIO vs WIMI Comparison

Compare GBIO & WIMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GBIO
  • WIMI
  • Stock Information
  • Founded
  • GBIO 2016
  • WIMI 2015
  • Country
  • GBIO United States
  • WIMI China
  • Employees
  • GBIO N/A
  • WIMI 107
  • Industry
  • GBIO Biotechnology: Pharmaceutical Preparations
  • WIMI Computer Software: Prepackaged Software
  • Sector
  • GBIO Health Care
  • WIMI Technology
  • Exchange
  • GBIO Nasdaq
  • WIMI Nasdaq
  • Market Cap
  • GBIO 29.2M
  • WIMI 23.9M
  • IPO Year
  • GBIO 2020
  • WIMI 2020
  • Fundamental
  • Price
  • GBIO $0.38
  • WIMI $3.41
  • Analyst Decision
  • GBIO Strong Buy
  • WIMI
  • Analyst Count
  • GBIO 4
  • WIMI 0
  • Target Price
  • GBIO $7.33
  • WIMI N/A
  • AVG Volume (30 Days)
  • GBIO 1.1M
  • WIMI 7.6M
  • Earning Date
  • GBIO 08-06-2025
  • WIMI 01-01-0001
  • Dividend Yield
  • GBIO N/A
  • WIMI N/A
  • EPS Growth
  • GBIO N/A
  • WIMI N/A
  • EPS
  • GBIO N/A
  • WIMI N/A
  • Revenue
  • GBIO $24,556,000.00
  • WIMI $84,137,968.00
  • Revenue This Year
  • GBIO N/A
  • WIMI N/A
  • Revenue Next Year
  • GBIO N/A
  • WIMI N/A
  • P/E Ratio
  • GBIO N/A
  • WIMI N/A
  • Revenue Growth
  • GBIO 146.47
  • WIMI 19.25
  • 52 Week Low
  • GBIO $0.30
  • WIMI $0.27
  • 52 Week High
  • GBIO $3.65
  • WIMI $2.92
  • Technical
  • Relative Strength Index (RSI)
  • GBIO 49.21
  • WIMI 53.23
  • Support Level
  • GBIO $0.32
  • WIMI $2.73
  • Resistance Level
  • GBIO $0.36
  • WIMI $3.09
  • Average True Range (ATR)
  • GBIO 0.03
  • WIMI 0.24
  • MACD
  • GBIO 0.00
  • WIMI 0.12
  • Stochastic Oscillator
  • GBIO 64.67
  • WIMI 85.11

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

About WIMI WiMi Hologram Cloud Inc.

WiMi Hologram Cloud Inc and its subsidiaries offer augmented reality (AR) based holographic services and products to cater to its customers. Its AR service and product offerings consist of holographic AR advertising services and holographic AR entertainment products. It is also into the semiconductor business, in which the company provides central processing algorithm services and computer chip products to enterprise customers and the sales of comprehensive solutions for central processing algorithms and related services with software and hardware integration. The company reports in three segments: AR advertising, AR entertainment, and Semiconductor. Its geographical segments are Mainland China, Hong Kong, and International.

Share on Social Networks: